These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3733003)

  • 21. Anti-fibrotic effect of malotilate on liver fibrosis induced by carbon tetrachloride in rats.
    Igarashi S; Hatahara T; Nagai Y; Hori H; Sakakibara K; Katoh M; Sakai A; Sugimoto T
    Jpn J Exp Med; 1986 Oct; 56(5):235-45. PubMed ID: 3027433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cimetidine prevents and partially reverses CCl4-induced liver cirrhosis.
    Mera E; Muriel P; Castillo C; Mourelle M
    J Appl Toxicol; 1994; 14(2):87-90. PubMed ID: 7913103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of vitamin A administration on collagen and sulfated glycosaminoglycans contents in the livers of rats treated with carbon tetrachloride.
    Parise ER; Chehter L; Nogueira MD; Leite-Mor MM; Tersariol IL; Michelacci YM; Nader HB
    J Lab Clin Med; 1992 Jun; 119(6):676-81. PubMed ID: 1593214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oral dosing vehicles on the subchronic hepatotoxicity of carbon tetrachloride in the rat.
    Koporec KP; Kim HJ; MacKenzie WF; Bruckner JV
    J Toxicol Environ Health; 1995 Jan; 44(1):13-27. PubMed ID: 7823328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of CCl4-induced liver injury by ketonic and ketogenic compounds: role of the CCl4 dose.
    Pilon D; Brodeur J; Plaa GL
    Toxicol Appl Pharmacol; 1988 Jun; 94(2):183-90. PubMed ID: 3388417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug metabolizing activity in rats with chronic liver injury induced by carbon tetrachloride: relationship with the content of hydroxyproline in the liver.
    Okuno H; Hazama H; Murase T; Shiozaki Y; Sameshima Y
    Jpn J Pharmacol; 1986 Jul; 41(3):363-71. PubMed ID: 3761752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver cirrhosis induced by carbon tetrachloride and the effect of superoxide dismutase and xanthine oxidase inhibitor treatment.
    Dashti HM; al-Sayer H; Behbehani A; Madda J; Christenson JT
    J R Coll Surg Edinb; 1992 Feb; 37(1):23-8. PubMed ID: 1573602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylcellulose prevents the regression of carbon tetrachloride-induced liver fibrosis and cirrhosis in rats.
    Szende B; Jeney A; Lapis K
    J Toxicol Environ Health; 1990; 29(1):59-63. PubMed ID: 2299687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-carotene (provitamin A) decreases the severity of CCl4-induced hepatic inflammation and fibrosis in rats.
    Seifert WF; Bosma A; Hendriks HF; van Leeuwen RE; van Thiel-de Ruiter GC; Seifert-Bock I; Knook DL; Brouwer A
    Liver; 1995 Feb; 15(1):1-8. PubMed ID: 7776851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related susceptibility to chlordecone-potentiated carbon tetrachloride hepatotoxicity and lethality is due to hepatic quiescence.
    Dalu A; Warbritton A; Bucci TJ; Mehendale HM
    Pediatr Res; 1995 Aug; 38(2):140-8. PubMed ID: 7478807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excessive hepatic accumulation of intracellular Ca2+ in chlordecone potentiated CCl4 toxicity.
    Agarwal AK; Mehendale HM
    Toxicology; 1984 Feb; 30(1):17-24. PubMed ID: 6199871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of KF-14363 on liver fibrosis in rats with chronic liver injury induced by carbon tetrachloride.
    Yoshitake I; Ohishi E; Sano J; Mori T; Kubo K
    J Pharmacobiodyn; 1991 Dec; 14(12):679-85. PubMed ID: 1812277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of antifibrotic activity of some magnesium-containing supplements on experimental liver toxicity. Molecular study.
    El-Tantawy WH; Sabry D; Abd Al Haleem EN
    Drug Chem Toxicol; 2017 Jan; 40(1):47-56. PubMed ID: 27151930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral dosing vehicles on the acute hepatotoxicity of carbon tetrachloride in rats.
    Kim HJ; Odend'hal S; Bruckner JV
    Toxicol Appl Pharmacol; 1990 Jan; 102(1):34-49. PubMed ID: 2296770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of acetone on the severity of the liver injury induced by haloalkane mixtures.
    Charbonneau M; Greselin E; Brodeur J; Plaa GL
    Can J Physiol Pharmacol; 1991 Dec; 69(12):1901-7. PubMed ID: 1802361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
    Matsuda Y; Matsumoto K; Yamada A; Ichida T; Asakura H; Komoriya Y; Nishiyama E; Nakamura T
    Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of malotilate (diisopropyl 1, 3-dithiol-2-ylidenemalonate) on chronic liver injury caused by carbon tetrachloride].
    Katoh M; Sugimoto T
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):83-91. PubMed ID: 7173736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
    Yao HW; Li J; Chen JQ; Xu SY
    Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.